Patent · US Active

Biocatalysts for Ezetimibe synthesis

US9388391B2 · kind B2 · utility

4Cited by
33References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 22, 2015
Grant dateJul 12, 2016
Priority date
Expiry dateApr 22, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12P17/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to non-naturally occurring polypeptides useful for preparing Ezetimibe, polynucleotides encoding the polypeptides, and methods of using the polypeptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.